Tamsulosin hydrochloride
- Product NDC
- 68071-4157
- 11-digit product format
- 680714157
- Labeler code
- 68071
- Product ID
- 68071-4157_5e21cb89-20a6-435d-e053-2a91aa0ad9c3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tamsulosin hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA078801
- Marketing category
- ANDA
- Marketing start
- 2010-04-27
- Marketing end
- 0000-00-00
- Substance
- TAMSULOSIN HYDROCHLORIDE
- Active strength
- 0 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-4157-1 | 2021-05-12 | C162847 | 48780-1 | ba0f9c33-188f-a910-e053-dadaa90a0b85 | 5e21cd7c-13e7-2469-e053-2991aa0a0d3f |
| 68071-4157-3 | 2021-05-12 | C162847 | 48780-1 | ba0f9c33-188f-a910-e053-dadaa90a0b85 | 5e21cd7c-13e7-2469-e053-2991aa0a0d3f |
| 68071-4157-6 | 2021-05-12 | C162847 | 48780-1 | ba0f9c33-188f-a910-e053-dadaa90a0b85 | 5e21cd7c-13e7-2469-e053-2991aa0a0d3f |
| 68071-4157-9 | 2021-05-12 | C162847 | 48780-1 | ba0f9c33-188f-a910-e053-dadaa90a0b85 | 5e21cd7c-13e7-2469-e053-2991aa0a0d3f |
| 68071-4157-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-188f-a910-e053-dadaa90a0b85 | 5e21cd7c-13e7-2469-e053-2991aa0a0d3f |
| 68071-4157-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-188f-a910-e053-dadaa90a0b85 | 5e21cd7c-13e7-2469-e053-2991aa0a0d3f |
| 68071-4157-6 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-188f-a910-e053-dadaa90a0b85 | 5e21cd7c-13e7-2469-e053-2991aa0a0d3f |
| 68071-4157-9 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-188f-a910-e053-dadaa90a0b85 | 5e21cd7c-13e7-2469-e053-2991aa0a0d3f |